表紙
市場調査レポート

米国、メキシコ、カナダの腎臓移植市場:件数と予測

Kidney Transplant Market, Numbers & Forecast for United States, Mexico & Canada

発行 Renub Research 商品コード 324757
出版日 ページ情報 英文 53 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=105.69円で換算しております。
Back to Top
米国、メキシコ、カナダの腎臓移植市場:件数と予測 Kidney Transplant Market, Numbers & Forecast for United States, Mexico & Canada
出版日: 2015年02月23日 ページ情報: 英文 53 Pages
概要

北米は、世界最大の腎移植市場の1つです。2014年、北米で実施された移植総数は、2万件を超えました。医療費の高さにもかかわらず、米国の腎臓移植市場は、今では10億ドル産業となっています。

当レポートでは、北米 (米国、メキシコ、カナダ) の腎臓移植市場について調査分析し、件数、市場、市場シェアに焦点を当てて、医薬品売上高分析、成長促進要因、課題なども含めて、体系的な情報を提供しています。

第1章 エグゼクティブサマリー

第2章 北米 (米国、メキシコ、カナダ) :腎臓移植の件数と予測

第3章 北米 (米国、メキシコ、カナダ) :腎臓移植市場と予測

第4章 北米 (米国、メキシコ、カナダ) :腎臓移植の件数、市場・医薬品市場シェア、予測

  • 北米 (米国、メキシコ、カナダ) :腎臓移植の件数と予測
  • 北米 (米国、メキシコ、カナダ) :腎臓移植市場シェアと予測
  • 米国、メキシコ、カナダの腎臓移植センターの数

第5章 米国

  • 米国:腎臓移植の件数と予測
  • 米国:腎臓移植市場と予測

第6章 メキシコ

  • メキシコ:腎臓移植の件数と予測
  • メキシコ:腎臓移植市場と予測

第7章 カナダ

  • カナダ:腎臓移植の件数と予測
  • カナダ:腎臓移植市場と予測

第8章 腎臓移植術 (免疫抑制剤) 医薬品売上高分析

  • CellCept (MycophenolateMofetil)
  • Prograf (Tacrolimus)
  • Rapamune (Sirolimus)
  • Myfortic (Mycophenolic Acid)
  • Neoral/Sandimmune (Cyclosporine)
  • Zortress/Certican (Everolimus)

第9章 腎臓移植市場の成長促進要因

  • 生体腎提供の頻度が増加
  • 腎移植患者は透析患者より通常は長生き

第10章 腎臓移植市場の課題

  • 腎移植待機期間が長い

図表

目次

SUMMARY

The improvement in technology, surgical techniques and immunosuppressive drugs, Kidney transplantation has became the preferred treatment for chronic kidney disease for many people. A transplant may offer the best chance of returning to a more normal life. Kidney transplantation has increasingly become a pivotal intervention for thousands of patients suffering from fatal end stage kidney disease (ESRD).

North America is one of the biggest kidney transplant market in the world. The overall number of Kidney Transplant done in North America (United States, Mexico and Canada) was more than 20 Thousand in 2014. United States is the leader in kidney transplant market in North America. Canada has the least number of kidney transplant done in comparison to United States and Mexico. Despite its high medical cost today United States Kidney Transplant Market is a Billion US$ industry.

Renub Research study titled “Kidney Transplant Market, Numbers & Forecast for United States, Mexico & Canada” explores a comprehensive assessment of the fast-evolving, high growth Kidney Transplant Market. This 53 page report with 33 Figures & 1 Table provides the number of kidney transplant, as well as market and market shares of Kidney Transplant Market. The report entails major kidney transplant (Immunosuppressant) drug sales analysis. This report also covers drivers and challenges of North America (United States, Mexico and Canada) market.

All the 3 Countries studied in the report are as follows:

  • 1) United States
  • 2) Canada
  • 3) Mexico

All the 6 Kidney Transplant Immunosuppressant) drugs studied in the report are as follows:

  • 1) CellCept (MycophenolateMofetil)
  • 2) Prograf (Tacrolimus)
  • 3) Rapamune (Sirolimus)
  • 4) Myfortic (Mycophenolic Acid)
  • 5) Neoral / Sandimmune (Cyclosporine)
  • 6) Zortress / Certican (Everolimus)

Table of Contents

1. Executive Summary

2. North America (United States, Mexico & Canada) - Number of Kidney Transplant & Forecast

3. North America (United States, Mexico & Canada) - Kidney Transplant Market & Forecast

4. North America (United States, Mexico & Canada) - Number of Kidney Transplant, Market & Drugs Market Share & Forecast

  • 4.1. North America (United States, Mexico & Canada) - Number of Kidney Transplant Share & Forecast
  • 4.2. North America (United States, Mexico & Canada) - Kidney Transplant Market Share & Forecast
  • 4.3. Number of Kidney Transplant Centers in United States, Canada & Mexico

5. United States

  • 5.1. United States - Number of Kidney Transplant & Forecast
  • 5.2. United States - Kidney Transplant Market & Forecast

6. Mexico

  • 6.1. Mexico - Number of Kidney Transplant & Forecast
  • 6.2. Mexico - Kidney Transplant Market & Forecast

7. Canada

  • 7.1. Canada - Number of Kidney Transplant & Forecast
  • 7.2. Canada - Kidney Transplant Market & Forecast

8. Kidney Transplantation (Immunosuppressant) Drug Sales Analysis

  • 8.1. CellCept (MycophenolateMofetil) Drugs Sales & Forecast
  • 8.2. Prograf (Tacrolimus) Drug Sales & Forecast
  • 8.3. Rapamune (Sirolimus) Drug Sales & Forecast
  • 8.4. Myfortic (Mycophenolic Acid) Drug Sales & Forecast
  • 8.5. Neoral / Sandimmune (Cyclosporine) Drug Sales & Forecast
  • 8.6. Zortress / Certican (Everolimus) Drug Sales & Forecast

9. Growth Drivers in the Kidney Transplant Market

  • 9.1. Frequency of Living Related Kidney Donation Has Increased
  • 9.2. Patients Who Have Kidney Transplants Usually Live Longer Than Patients Receiving Dialysis

10. Challenges in the Kidney Transplant Market

  • 10.1. Kidney Transplant Waitlist is Long

LIST OF FIGURES

  • Figure 2-1: North America (United States, Mexico & Canada) - Number of Kidney Transplant (Number), 2006 - 2014
  • Figure 2-2: North America (United States, Mexico & Canada) - Forecast for Number of Kidney Transplant (Number), 2015 - 2020
  • Figure 3-1: North America (United States, Mexico & Canada) - Kidney Transplant Market (Million US$), 2006 - 2014
  • Figure 3-2: North America (United States, Mexico & Canada) - Forecast for Kidney Transplant Market (Million US$), 2015 - 2020
  • Figure 4-1: North America (United States, Mexico & Canada) - Number of Kidney Transplant Share (Percent), 2006 - 2014
  • Figure 4-2: North America (United States, Mexico & Canada) - Forecast for Number of Kidney Transplant Share (Percent), 2015 - 2020
  • Figure 4-3: North America (United States, Mexico & Canada) - Kidney Transplant Market Share (Percent), 2006 - 2014
  • Figure 4-4: North America (United States, Mexico & Canada) - Kidney Transplant Market Share (Percent), 2015 - 2020
  • Figure 5-1: United States - Number of Kidney Transplant (Number), 2004 - 2014
  • Figure 5-2: United States - Forecast for Number of Kidney Transplant (Number), 2015 - 2020
  • Figure 5-3: United States - Kidney Transplant Market (Million US$), 2004 - 2014
  • Figure 5-4: United States - Forecast for Kidney Transplant Market (Million US$), 2015 - 2020
  • Figure 6-1: Mexico - Number of Kidney Transplant (Number), 2006 - 2014
  • Figure 6-2: Mexico - Forecast for number of Kidney Transplant (Number), 2015 - 2020
  • Figure 6-3: Mexico - Kidney Transplant Market (Million US$), 2006 - 2014
  • Figure 6-4: Mexico - Forecast for Kidney Transplant Market (Million US$), 2015 - 2020
  • Figure 7-1: Canada - Number of Kidney Transplant (Number), 2004 - 2014
  • Figure 7-2: Canada - Forecast for number of Kidney Transplant (Number), 2015 - 2020
  • Figure 7-3: Canada - Kidney Transplant Market (Million US$), 2004 - 2014
  • Figure 7-4: Canada - Forecast for Kidney Transplant Market (Million US$), 2015 - 2020
  • Figure 9-1: Worldwide - CellCept Drug Sales (Million US$), 2005 - 2014
  • Figure 9-2: Worldwide - Forecast for CellCept Drug Sales (Million US$), 2015 - 2020
  • Figure 9-3: Worldwide - Prograf Drug Sales (Million US$), 2004 - 2014
  • Figure 9-4: Worldwide - Forecast for Prograf Drug Sales (Million US$), 2015 - 2020
  • Figure 9-5: Worldwide - Rapamune Drug Sales (Million US$), 2009 - 2014
  • Figure 9-6: Worldwide - Forecast for Rapamune Drug Sales (Million US$), 2015 - 2020
  • Figure 9-7: Worldwide - Myfortic Drug Sales (Million US$), 2008 - 2014
  • Figure 9-8: Worldwide - Forecast for Myfortic Drug Sales (Million US$), 2015 - 2020
  • Figure 9-9: Worldwide - Neoral / Sandimmune Drug Sales (Million US$), 2007 - 2014
  • Figure 9-10: Worldwide - Neoral / Sandimmune Drug Sales (Million US$), 2015 - 2020
  • Figure 9-11: Worldwide - Zortress/Certican Drug Sales (Million US$), 2008 - 2014
  • Figure 9-12: Worldwide - Forecast for Zortress / Certican Drug Sales (Million US$), 2015 - 2020
  • Figure 10-1: United States - Number of Kidney Living Donor (Number), 2000 - 2013

LIST OF TABLES

  • Table 4-1: United States, Mexico & Canada - Kidney Transplant Centers (Number), 2014
Back to Top